About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: August 2015
Weekly Roundup 8.21.15
We are at the end of summer. Though not young, my mental calendar is still locked into the mentality regarding the beginning of school. This is the last week to relax before the onslaught of back to school, days full … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 8.21.15
Weekly Roundup 8.14.15
The summer is flying by. The lightning bugs have lit up and lit out. The grass has had it. Vacations are nearing an end. The last of the picnics are being planned. Somewhere someone is busy tuning up the yellow … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 8.14.15
OPDP Issues Warning Letter on Social Media Posting
OMG. Can’t say that I ever thought I would be writing about Kim Kardashian here on Eye on FDA, but that just goes to show you, life always entertains surprises. This week FDA posted a Warning Letter issued to a … Continue reading
Posted in Warning Letters
Comments Off on OPDP Issues Warning Letter on Social Media Posting
Weekly Roundup 8.7.15
The dog days of Summer are upon us. No matter what one does, it seems, lawns turn a faded color. Bright daisies and black-eyed Susan flowers dance lazily in gentle breezes. Gazpacho can be a complete meal. The porch swing, … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 8.7.15
Twitter Followers and Pharma – The New Numbers
As many readers are aware, I love databases and one of them that I have put together takes a stab at tracking social media activity of the pharma, biotech and device sectors. Included in the count are any pharma Twitter … Continue reading
Posted in Social Media
Comments Off on Twitter Followers and Pharma – The New Numbers